There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

If you take a GLP-1 medication, like Ozempic, Wegovy, Mounjaro, or Zepbound, you may want to take a look at your diet. These ...

LBC can reveal the Advertising Standards Authority issued a warning to a weight loss treatment provider over an advert which ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

This and the week’s other couture collections were unveiled as luxury groups wrestle with a year-long spending slowdown, ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...